Global Vitamin D Analogs Sales Market Report 2016

December 2016 | 113 pages | ID: G4B009EDA4FEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Vitamin D Analogs

Revenue, means the sales value of Vitamin D Analogs

This report studies sales (consumption) of Vitamin D Analogs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Blistex, Inc. (US)
• Chattem, Inc. (US)
• ConvaTec (US)
• Galderma Pharma SA (Switzerland)
• Henkel AG & Co. KgaA (Germany)
• Johnson & Johnson (US)
• Neutrogena Corp (US)
• Merck & Co. (US)
• Decartis AG (Switzerland)
• Obagi Medical Products, Inc. (US)
• Procter & Gamble Company (US)
• Reckitt Benckiser Plc. (UK)
• Rohto Pharmaceutical Co., Ltd. (Japan)
• Shiseido Co., Ltd. (Japan)
• Unilever NV (The Netherlands)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Vitamin D Analogs in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Vitamin D Analogs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Vitamin D Analogs Sales Market Report 2016

1 VITAMIN D ANALOGS OVERVIEW

1.1 Product Overview and Scope of Vitamin D Analogs
1.2 Classification of Vitamin D Analogs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Vitamin D Analogs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Vitamin D Analogs Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Vitamin D Analogs (2011-2021)
  1.5.1 Global Vitamin D Analogs Sales and Growth Rate (2011-2021)
  1.5.2 Global Vitamin D Analogs Revenue and Growth Rate (2011-2021)

2 GLOBAL VITAMIN D ANALOGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Vitamin D Analogs Market Competition by Manufacturers
  2.1.1 Global Vitamin D Analogs Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Vitamin D Analogs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Vitamin D Analogs (Volume and Value) by Type
  2.2.1 Global Vitamin D Analogs Sales and Market Share by Type (2011-2016)
  2.2.2 Global Vitamin D Analogs Revenue and Market Share by Type (2011-2016)
2.3 Global Vitamin D Analogs (Volume and Value) by Regions
  2.3.1 Global Vitamin D Analogs Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Vitamin D Analogs Revenue and Market Share by Regions (2011-2016)
2.4 Global Vitamin D Analogs (Volume) by Application

3 UNITED STATES VITAMIN D ANALOGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Vitamin D Analogs Sales and Value (2011-2016)
  3.1.1 United States Vitamin D Analogs Sales and Growth Rate (2011-2016)
  3.1.2 United States Vitamin D Analogs Revenue and Growth Rate (2011-2016)
  3.1.3 United States Vitamin D Analogs Sales Price Trend (2011-2016)
3.2 United States Vitamin D Analogs Sales and Market Share by Manufacturers
3.3 United States Vitamin D Analogs Sales and Market Share by Type
3.4 United States Vitamin D Analogs Sales and Market Share by Application

4 CHINA VITAMIN D ANALOGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Vitamin D Analogs Sales and Value (2011-2016)
  4.1.1 China Vitamin D Analogs Sales and Growth Rate (2011-2016)
  4.1.2 China Vitamin D Analogs Revenue and Growth Rate (2011-2016)
  4.1.3 China Vitamin D Analogs Sales Price Trend (2011-2016)
4.2 China Vitamin D Analogs Sales and Market Share by Manufacturers
4.3 China Vitamin D Analogs Sales and Market Share by Type
4.4 China Vitamin D Analogs Sales and Market Share by Application

5 EUROPE VITAMIN D ANALOGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Vitamin D Analogs Sales and Value (2011-2016)
  5.1.1 Europe Vitamin D Analogs Sales and Growth Rate (2011-2016)
  5.1.2 Europe Vitamin D Analogs Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Vitamin D Analogs Sales Price Trend (2011-2016)
5.2 Europe Vitamin D Analogs Sales and Market Share by Manufacturers
5.3 Europe Vitamin D Analogs Sales and Market Share by Type
5.4 Europe Vitamin D Analogs Sales and Market Share by Application

6 JAPAN VITAMIN D ANALOGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Vitamin D Analogs Sales and Value (2011-2016)
  6.1.1 Japan Vitamin D Analogs Sales and Growth Rate (2011-2016)
  6.1.2 Japan Vitamin D Analogs Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Vitamin D Analogs Sales Price Trend (2011-2016)
6.2 Japan Vitamin D Analogs Sales and Market Share by Manufacturers
6.3 Japan Vitamin D Analogs Sales and Market Share by Type
6.4 Japan Vitamin D Analogs Sales and Market Share by Application

7 GLOBAL VITAMIN D ANALOGS MANUFACTURERS ANALYSIS

7.1 Blistex, Inc. (US)
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Vitamin D Analogs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Blistex, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Chattem, Inc. (US)
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 113 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Chattem, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 ConvaTec (US)
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 132 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 ConvaTec (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Galderma Pharma SA (Switzerland)
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Galderma Pharma SA (Switzerland) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Henkel AG & Co. KgaA (Germany)
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Henkel AG & Co. KgaA (Germany) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Johnson & Johnson (US)
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Johnson & Johnson (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Neutrogena Corp (US)
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Chemical & Material Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Neutrogena Corp (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Merck & Co. (US)
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Merck & Co. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Decartis AG (Switzerland)
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Decartis AG (Switzerland) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Obagi Medical Products, Inc. (US)
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Obagi Medical Products, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Procter & Gamble Company (US)
7.12 Reckitt Benckiser Plc. (UK)
7.13 Rohto Pharmaceutical Co., Ltd. (Japan)
7.14 Shiseido Co., Ltd. (Japan)
7.15 Unilever NV (The Netherlands)

8 VITAMIN D ANALOGS MAUFACTURING COST ANALYSIS

8.1 Vitamin D Analogs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Vitamin D Analogs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Vitamin D Analogs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Vitamin D Analogs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL VITAMIN D ANALOGS MARKET FORECAST (2016-2021)

12.1 Global Vitamin D Analogs Sales, Revenue Forecast (2016-2021)
12.2 Global Vitamin D Analogs Sales Forecast by Regions (2016-2021)
12.3 Global Vitamin D Analogs Sales Forecast by Type (2016-2021)
12.4 Global Vitamin D Analogs Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Vitamin D Analogs
Table Classification of Vitamin D Analogs
Figure Global Sales Market Share of Vitamin D Analogs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Vitamin D Analogs
Figure Global Sales Market Share of Vitamin D Analogs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Vitamin D Analogs Revenue and Growth Rate (2011-2021)
Figure China Vitamin D Analogs Revenue and Growth Rate (2011-2021)
Figure Europe Vitamin D Analogs Revenue and Growth Rate (2011-2021)
Figure Japan Vitamin D Analogs Revenue and Growth Rate (2011-2021)
Figure Global Vitamin D Analogs Sales and Growth Rate (2011-2021)
Figure Global Vitamin D Analogs Revenue and Growth Rate (2011-2021)
Table Global Vitamin D Analogs Sales of Key Manufacturers (2011-2016)
Table Global Vitamin D Analogs Sales Share by Manufacturers (2011-2016)
Figure 2015 Vitamin D Analogs Sales Share by Manufacturers
Figure 2016 Vitamin D Analogs Sales Share by Manufacturers
Table Global Vitamin D Analogs Revenue by Manufacturers (2011-2016)
Table Global Vitamin D Analogs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Vitamin D Analogs Revenue Share by Manufacturers
Table 2016 Global Vitamin D Analogs Revenue Share by Manufacturers
Table Global Vitamin D Analogs Sales and Market Share by Type (2011-2016)
Table Global Vitamin D Analogs Sales Share by Type (2011-2016)
Figure Sales Market Share of Vitamin D Analogs by Type (2011-2016)
Figure Global Vitamin D Analogs Sales Growth Rate by Type (2011-2016)
Table Global Vitamin D Analogs Revenue and Market Share by Type (2011-2016)
Table Global Vitamin D Analogs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Vitamin D Analogs by Type (2011-2016)
Figure Global Vitamin D Analogs Revenue Growth Rate by Type (2011-2016)
Table Global Vitamin D Analogs Sales and Market Share by Regions (2011-2016)
Table Global Vitamin D Analogs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Vitamin D Analogs by Regions (2011-2016)
Figure Global Vitamin D Analogs Sales Growth Rate by Regions (2011-2016)
Table Global Vitamin D Analogs Revenue and Market Share by Regions (2011-2016)
Table Global Vitamin D Analogs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Vitamin D Analogs by Regions (2011-2016)
Figure Global Vitamin D Analogs Revenue Growth Rate by Regions (2011-2016)
Table Global Vitamin D Analogs Sales and Market Share by Application (2011-2016)
Table Global Vitamin D Analogs Sales Share by Application (2011-2016)
Figure Sales Market Share of Vitamin D Analogs by Application (2011-2016)
Figure Global Vitamin D Analogs Sales Growth Rate by Application (2011-2016)
Figure United States Vitamin D Analogs Sales and Growth Rate (2011-2016)
Figure United States Vitamin D Analogs Revenue and Growth Rate (2011-2016)
Figure United States Vitamin D Analogs Sales Price Trend (2011-2016)
Table United States Vitamin D Analogs Sales by Manufacturers (2011-2016)
Table United States Vitamin D Analogs Market Share by Manufacturers (2011-2016)
Table United States Vitamin D Analogs Sales by Type (2011-2016)
Table United States Vitamin D Analogs Market Share by Type (2011-2016)
Table United States Vitamin D Analogs Sales by Application (2011-2016)
Table United States Vitamin D Analogs Market Share by Application (2011-2016)
Figure China Vitamin D Analogs Sales and Growth Rate (2011-2016)
Figure China Vitamin D Analogs Revenue and Growth Rate (2011-2016)
Figure China Vitamin D Analogs Sales Price Trend (2011-2016)
Table China Vitamin D Analogs Sales by Manufacturers (2011-2016)
Table China Vitamin D Analogs Market Share by Manufacturers (2011-2016)
Table China Vitamin D Analogs Sales by Type (2011-2016)
Table China Vitamin D Analogs Market Share by Type (2011-2016)
Table China Vitamin D Analogs Sales by Application (2011-2016)
Table China Vitamin D Analogs Market Share by Application (2011-2016)
Figure Europe Vitamin D Analogs Sales and Growth Rate (2011-2016)
Figure Europe Vitamin D Analogs Revenue and Growth Rate (2011-2016)
Figure Europe Vitamin D Analogs Sales Price Trend (2011-2016)
Table Europe Vitamin D Analogs Sales by Manufacturers (2011-2016)
Table Europe Vitamin D Analogs Market Share by Manufacturers (2011-2016)
Table Europe Vitamin D Analogs Sales by Type (2011-2016)
Table Europe Vitamin D Analogs Market Share by Type (2011-2016)
Table Europe Vitamin D Analogs Sales by Application (2011-2016)
Table Europe Vitamin D Analogs Market Share by Application (2011-2016)
Figure Japan Vitamin D Analogs Sales and Growth Rate (2011-2016)
Figure Japan Vitamin D Analogs Revenue and Growth Rate (2011-2016)
Figure Japan Vitamin D Analogs Sales Price Trend (2011-2016)
Table Japan Vitamin D Analogs Sales by Manufacturers (2011-2016)
Table Japan Vitamin D Analogs Market Share by Manufacturers (2011-2016)
Table Japan Vitamin D Analogs Sales by Type (2011-2016)
Table Japan Vitamin D Analogs Market Share by Type (2011-2016)
Table Japan Vitamin D Analogs Sales by Application (2011-2016)
Table Japan Vitamin D Analogs Market Share by Application (2011-2016)
Table Blistex, Inc. (US) Basic Information List
Table Blistex, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Blistex, Inc. (US) Vitamin D Analogs Global Market Share (2011-2016)
Table Chattem, Inc. (US) Basic Information List
Table Chattem, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Chattem, Inc. (US) Vitamin D Analogs Global Market Share (2011-2016)
Table ConvaTec (US) Basic Information List
Table ConvaTec (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ConvaTec (US) Vitamin D Analogs Global Market Share (2011-2016)
Table Galderma Pharma SA (Switzerland) Basic Information List
Table Galderma Pharma SA (Switzerland) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Galderma Pharma SA (Switzerland) Vitamin D Analogs Global Market Share (2011-2016)
Table Henkel AG & Co. KgaA (Germany) Basic Information List
Table Henkel AG & Co. KgaA (Germany) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Henkel AG & Co. KgaA (Germany) Vitamin D Analogs Global Market Share (2011-2016)
Table Johnson & Johnson (US) Basic Information List
Table Johnson & Johnson (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson (US) Vitamin D Analogs Global Market Share (2011-2016)
Table Neutrogena Corp (US) Basic Information List
Table Neutrogena Corp (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Neutrogena Corp (US) Vitamin D Analogs Global Market Share (2011-2016)
Table Merck & Co. (US) Basic Information List
Table Merck & Co. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. (US) Vitamin D Analogs Global Market Share (2011-2016)
Table Decartis AG (Switzerland) Basic Information List
Table Decartis AG (Switzerland) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Decartis AG (Switzerland) Vitamin D Analogs Global Market Share (2011-2016)
Table Obagi Medical Products, Inc. (US) Basic Information List
Table Obagi Medical Products, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Obagi Medical Products, Inc. (US) Vitamin D Analogs Global Market Share (2011-2016)
Table Procter & Gamble Company (US) Basic Information List
Table Procter & Gamble Company (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Procter & Gamble Company (US) Vitamin D Analogs Global Market Share (2011-2016)
Table Reckitt Benckiser Plc. (UK) Basic Information List
Table Reckitt Benckiser Plc. (UK) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Reckitt Benckiser Plc. (UK) Vitamin D Analogs Global Market Share (2011-2016)
Table Rohto Pharmaceutical Co., Ltd. (Japan) Basic Information List
Table Rohto Pharmaceutical Co., Ltd. (Japan) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Rohto Pharmaceutical Co., Ltd. (Japan) Vitamin D Analogs Global Market Share (2011-2016)
Table Shiseido Co., Ltd. (Japan) Basic Information List
Table Shiseido Co., Ltd. (Japan) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Shiseido Co., Ltd. (Japan) Vitamin D Analogs Global Market Share (2011-2016)
Table Unilever NV (The Netherlands) Basic Information List
Table Unilever NV (The Netherlands) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Unilever NV (The Netherlands) Vitamin D Analogs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vitamin D Analogs
Figure Manufacturing Process Analysis of Vitamin D Analogs
Figure Vitamin D Analogs Industrial Chain Analysis
Table Raw Materials Sources of Vitamin D Analogs Major Manufacturers in 2015
Table Major Buyers of Vitamin D Analogs
Table Distributors/Traders List
Figure Global Vitamin D Analogs Sales and Growth Rate Forecast (2016-2021)
Figure Global Vitamin D Analogs Revenue and Growth Rate Forecast (2016-2021)
Table Global Vitamin D Analogs Sales Forecast by Regions (2016-2021)
Table Global Vitamin D Analogs Sales Forecast by Type (2016-2021)
Table Global Vitamin D Analogs Sales Forecast by Application (2016-2021)